Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_06-cv-00564/USCOURTS-cand-3_06-cv-00564-0/pdf.json

Parties Involved:
AstraZeneca Pharmaceuticals, L.P.
Defendant
Astrazeneca, L.P.
Defendant
Eddi Glover
Plaintiff

Document Text:

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

For the Northern District of California

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

EDDI GLOVER,

Plaintiff,

 v.

ASTRAZENECA PHARMACEUTICALS, L.P.

and ASTRAZENECA, L.P.,

Defendants.

 /

No. C-06-0564 MMC

ORDER CONTINUING CASE

MANAGEMENT CONFERENCE

Before the Court is plaintiff’s Case Management Conference Statement, filed May 2,

2006, by which plaintiff seeks to continue the May 12, 2006 case management conference

in the instant action by approximately 120 days. Plaintiff states a continuance is necessary

because plaintiff anticipates the instant action will be transferred for inclusion in MDL No.

1769, In re Seroquel Products Liability Litigation, and because plaintiff has not yet served

the defendants. Because the instant action was filed January 27, 2006, the 120-day

deadline for plaintiff to serve defendants, pursuant to Rule 4(m) of the Federal Rules of

Civil Procedure, has not yet elapsed.

Accordingly, for good cause shown, the May 12, 2006 case management

conference is hereby continued to September 8, 2006 at 10:30 a.m. A joint case

Case 3:06-cv-00564-MMC Document 6 Filed 05/03/06 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

2

management statement shall be filed no later than September 1, 2006. The deadline to

serve defendants, pursuant to Rule 4(m) of the Federal Rules of Civil Procedure, remains

in effect.

IT IS SO ORDERED.

Dated: May 3, 2006 

MAXINE M. CHESNEY

United States District Judge

Case 3:06-cv-00564-MMC Document 6 Filed 05/03/06 Page 2 of 2